Geode Capital Management LLC Cuts Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Geode Capital Management LLC reduced its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 0.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 124,446 shares of the medical instruments supplier’s stock after selling 315 shares during the quarter. Geode Capital Management LLC owned 2.29% of Mesa Laboratories worth $16,415,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Barclays PLC grew its position in shares of Mesa Laboratories by 357.4% during the 3rd quarter. Barclays PLC now owns 8,837 shares of the medical instruments supplier’s stock valued at $1,148,000 after acquiring an additional 6,905 shares during the period. Franklin Resources Inc. raised its stake in shares of Mesa Laboratories by 27.8% in the third quarter. Franklin Resources Inc. now owns 6,444 shares of the medical instruments supplier’s stock worth $828,000 after buying an additional 1,403 shares during the period. Principal Financial Group Inc. lifted its position in shares of Mesa Laboratories by 21.8% during the 3rd quarter. Principal Financial Group Inc. now owns 35,107 shares of the medical instruments supplier’s stock valued at $4,559,000 after buying an additional 6,292 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Mesa Laboratories by 29.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 8,406 shares of the medical instruments supplier’s stock valued at $1,092,000 after acquiring an additional 1,906 shares during the period. Finally, State Street Corp increased its holdings in Mesa Laboratories by 9.2% in the 3rd quarter. State Street Corp now owns 214,148 shares of the medical instruments supplier’s stock worth $27,809,000 after acquiring an additional 18,128 shares in the last quarter. Institutional investors own 90.60% of the company’s stock.

Mesa Laboratories Stock Down 0.8 %

Shares of MLAB stock opened at $112.01 on Monday. Mesa Laboratories, Inc. has a 52 week low of $83.68 and a 52 week high of $155.12. The company has a quick ratio of 0.53, a current ratio of 0.71 and a debt-to-equity ratio of 0.61. The company’s fifty day simple moving average is $126.89 and its two-hundred day simple moving average is $127.62. The stock has a market cap of $608.66 million, a P/E ratio of -2.42 and a beta of 0.92.

Mesa Laboratories (NASDAQ:MLAB) last released its earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 30.23% and a negative net margin of 104.92%. Analysts predict that Mesa Laboratories, Inc. will post 8 EPS for the current fiscal year.

Mesa Laboratories Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Friday, May 30th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.64 annualized dividend and a dividend yield of 0.57%. Mesa Laboratories’s payout ratio is currently -1.38%.

Insider Buying and Selling

In other news, CEO Gary M. Owens sold 21,000 shares of Mesa Laboratories stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total transaction of $2,602,110.00. Following the completion of the transaction, the chief executive officer now directly owns 43,337 shares of the company’s stock, valued at $5,369,887.67. The trade was a 32.64 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 4.40% of the stock is owned by corporate insiders.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.